NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 47 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,618,000 | -21.0% | 14,292,619 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,642,000 | +174.8% | 14,292,619 | +134.2% | 0.00% | – |
| Q1 2020 | $3,509,000 | -56.6% | 6,103,392 | -0.5% | 0.00% | -100.0% |
| Q4 2019 | $8,094,000 | -18.4% | 6,131,900 | +23.6% | 0.00% | 0.0% |
| Q3 2019 | $9,919,000 | +16.4% | 4,959,700 | +41.4% | 0.00% | 0.0% |
| Q2 2019 | $8,522,000 | +7.1% | 3,507,100 | +7.5% | 0.00% | 0.0% |
| Q1 2019 | $7,958,000 | +195.8% | 3,261,500 | +77.0% | 0.00% | – |
| Q4 2018 | $2,690,000 | +232.1% | 1,842,700 | +514.2% | 0.00% | – |
| Q3 2018 | $810,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |